[ad_1]

Pulse Biosciences (NASDAQ:PLSE) and Restoration Robotics (NASDAQ:HAIR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.

Institutional & Insider Ownership

8.5% of Pulse Biosciences shares are owned by institutional investors. Comparatively, 27.8% of Restoration Robotics shares are owned by institutional investors. 48.6% of Pulse Biosciences shares are owned by insiders. Comparatively, 37.8% of Restoration Robotics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

Pulse Biosciences has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Comparatively, Restoration Robotics has a beta of 4.79, indicating that its stock price is 379% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Pulse Biosciences and Restoration Robotics, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pulse Biosciences 0 0 1 0 3.00
Restoration Robotics 0 3 0 0 2.00

Pulse Biosciences currently has a consensus target price of $27.00, suggesting a potential upside of 68.54%. Restoration Robotics has a consensus target price of $2.62, suggesting a potential upside of 321.36%. Given Restoration Robotics’ higher probable upside, analysts clearly believe Restoration Robotics is more favorable than Pulse Biosciences.

Profitability

This table compares Pulse Biosciences and Restoration Robotics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pulse Biosciences N/A -88.07% -80.02%
Restoration Robotics -130.83% -653.88% -92.94%

Valuation and Earnings

This table compares Pulse Biosciences and Restoration Robotics’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pulse Biosciences N/A N/A -$37.54 million N/A N/A
Restoration Robotics $21.96 million 1.15 -$28.73 million ($0.86) -0.72

Restoration Robotics has higher revenue and earnings than Pulse Biosciences.

Summary

Pulse Biosciences beats Restoration Robotics on 6 of the 11 factors compared between the two stocks.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc. operates as a clinical stage medical therapy company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.

Restoration Robotics Company Profile

Restoration Robotics, Inc., a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. The company offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites. Its system includes the ARTAS Hair Studio application, an interactive three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. The company was founded in 2002 and is headquartered in San Jose, California.

Receive News & Ratings for Pulse Biosciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Pulse Biosciences and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

Source link